GILD
Gilead Sciences, Inc.
B
71.7 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
13.3%
-
Operating Margin Trend
-1.42 pp/yr
-
5yr Avg ROE
23.2%
-
5yr Share-Count CAGR
-0.1%
-
5yr Revenue CAGR
3.6%
-
5yr EPS CAGR
133.7%
-
Revenue-Growth Years (5)
3/5
-
5yr FCF Margin
33.1%
-
5yr FCF/NI Conversion
5.49x
-
Net Debt / EBITDA
1.13x
-
Interest Coverage (EBIT/Int)
10.57x
-
Altman Z-Score
4.54
Stability
Weight: 15%
C-
47
-
EPS Volatility (σ/μ)
0.72
-
Negative-Revenue Years (5)
2/5
-
Piotroski F-Score
8
4 of 4 gurus held; 3 added; 1 trimmed.
- Holders
- 4
- Avg Δ position
-
+193.2%
- New buys
- 0
- Full exits
- 0